Stockscreener 앱 받기
8.06
7.18%
0.54
시간 외 거래:
7.52
-0.54
-6.70%
Hcw Biologics Inc 주식(HCWB)의 최신 뉴스
HCWB stock touches 52-week low at $6.99 amid sharp annual decline - Investing.com Australia
HCW Biologics (NASDAQ:HCWB) Trading 0.1% Higher – Here’s Why - Defense World
HCW Biologics faces lawsuit over construction contract breach - Investing.com Australia
HCW Biologics faces lawsuit over construction contract breach By Investing.com - Investing.com Canada
HCW Biologics enters key agreements; SEC non-review of filing By Investing.com - Investing.com South Africa
HCW Biologics enters key agreements; SEC non-review of filing - Investing.com
HCWB stock touches 52-week low at $8.04 amid market challenges By Investing.com - Investing.com South Africa
HCWB stock touches 52-week low at $8.04 amid market challenges - Investing.com Canada
HCWB stock touches 52-week low at $0.2 amid sharp annual decline By Investing.com - Investing.com South Africa
HCWB stock touches 52-week low at $0.2 amid sharp annual decline - Investing.com Australia
HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World
HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener
HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa
HCW Biologics Announces 1-for-40 Reverse Stock Split - citybiz
HCW Biologics approves reverse stock split - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
HCW Biologics Announces Reverse Stock Split Approval - TipRanks
HCW Biologics approves reverse stock split to meet Nasdaq rules - Investing.com
HCW Biologics approves 1-for-40 reverse stock split - TipRanks
HCW Biologics Announces 1-For-40 Reverse Stock Split - MarketScreener
HCW Biologics approves reverse stock split By Investing.com - Investing.com Canada
Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan
Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail
How major US stock indexes fared Tuesday, 4/1/2025 - The Globe and Mail
HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq
HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - The Manila Times
HCW Biologics Inc. SEC 10-K Report - TradingView
HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan
HCW Biologics amends agreement with WY Biotech amid delays - Investing.com
Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail
HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire
HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq
Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan
HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com
Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail
HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News
HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater
Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex
The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks
HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Penny Stocks To ResearchFebruary 03rd - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Pharma company granted FDA clearance for alopecia drug study - The Business Journals
1.73%
자본화:
|
볼륨(24시간):